捷芯隆(02115.HK)預計年度擁有人應占綜合純利減少約27%至32%
格隆匯3月12日丨捷芯隆(02115.HK)發佈公吿,公司預計截至2023年12月31日止年度公司擁有人應占未經審核綜合純利約人民幣51百萬元至人民幣55百萬元,較上年度公司擁有人應占經審核綜合溢利約人民幣75百萬元減少約27%至32%。
董事會認為,溢利減少乃主要由於集團收益減少,主要原因為(1)中美貿易緊張局勢對位於中國的半導體設施的投資及建設進度造成影響;及(2)經濟不確定性導致投資環境不明朗,尤其是半導體產業,加上終端電子產品需求疲軟,存貨增加及微晶片價格下降對我們的無塵室產品需求造成直接影響,尤其是中國市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.